Kaleido Biosciences to Participate in the Jefferies Virtual Next Generation IBD Therapeutics Summit
LEXINGTON, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated,...